Objective: To compare health service utilization and disability claims among military personnel with multisymptom illness (MSI) (but no chronic diseases), those with chronic disease(s) and those without MSI or chronic diseases. MSI is also known as Gulf War illness. Design: Cohort study. Setting: Australia. Participants: In total, 1288 participants of a Gulf War veterans' study conducted in [2000][2001][2002][2003] (Wave-1) were followed up in 2011-2012 (Wave-2), aged on average 40 years. About 160 had MSI, 217 had chronic disease(s) and 911 had neither chronic disease(s) nor MSI. Methods: At Wave-2, the cohort was linked to the national Medicare and Department of Veterans' Affairs (DVA) databases to obtain health service utilization and disability claims data recorded between 2001 and 2012. Results: The likelihood of visiting a general practitioner (GP) (risk ratio [RR] = 1.04, 95% confidence interval [CI] = 0.92, 1.19) or visiting a specialist medical doctor (RR = 0.83; 95% CI = 0.54, 1.28) or hospitalizations (RR = 0.89; 95% CI = 0.61, 1.29) or) in the 12 months preceding Wave-2 or successfully claiming for DVA disability compensation (RR = 1.13; 95% CI = 0.86, 1.47) was similar for personnel with MSI and those with chronic disease(s). However, GP consultations, hospitalizations, specialist doctor consultations and disability claims were significantly higher among those with MSI than those without MSI/chronic diseases. Conclusions: Health service use and disability claims by personnel with MSI were comparable to those with chronic disease(s), but were in excess of those without MSI/chronic diseases. Hence recognition of the high health service use by personnel with MSI is important to ensure adequate provision of health services.
Introduction
Multisymptom illness (MSI), sometimes referred to as chronic MSI or Gulf War illness, is a major health problem among Gulf War veterans [1] . Recent reports have suggested that this condition is also prevalent among personnel returning from more recent Iraq and Afghanistan deployments [2, 3] . The main characteristic among personnel with MSI is the reporting of multiple symptoms that cannot be explained pathologically or by a disease. While there exists evidence on the prevalence of MSI, less is understood about health service use among those with MSI. The existing meagre evidence suggests increased clinic visits among those with MSI compared with those without MSI [4] . However, little is known about other health service use outcomes such as consultations with specialist doctors or allied health professionals (e.g. physiotherapist, chiropractor and social workers). In the findings presented by Blanchard et al. [4] , participants with or without chronic diseases/illnesses were not separate therefore increasing the likelihood of misclassification bias in MSI definition as presence of chronic disease(s) is likely to influence symptomatology and MSI classification. Therefore, this paper uses a more stringent definition of MSI which differentiates those with diagnosed chronic diseases and those without.
Although research into MSI has been undertaken for over 20 years, lack of agreement on the aetiology or diagnosis may mean that military personnel with this condition may not be successful in claims for disability compensation as some compensation schemes require a doctor's diagnosis or known aetiology for a claim to be accepted. Therefore, where data are available, it is important to investigate the outcomes of disability claims in military personnel who develop MSI.
Using self-report and linkage data from a longitudinal study of Gulf War veterans and a service, age and rank-matched military comparison group, we compared health service use and disability compensation claims among military personnel categorized into three mutually exclusive groups: personnel with MSI (but without chronic diseases), personnel with chronic diseases (who may or may not exhibit symptom reporting identical to MSI) and personnel with neither MSI nor chronic diseases.
Methods

Cohort description
In 2000-2003 (Wave-1), a cohort comprising all Australian veterans of the 1990-1991 Gulf War and a military comparison group (military personnel who were serving in the Australian Defence Force at the time of the Gulf War but not deployed to the Gulf War) was compiled. In a follow-up study (Wave-2) (results not shown here) there were no significant differences in health service use between Gulf War veterans and the comparison; and at Wave-1 about onein-five (16%) participants in the comparison group were classified as having MSI [5] . Therefore, as the primary research questions in this paper were related to health service utilization and disability claims among military personnel with MSI (but no chronic diseases) regardless of Gulf War deployment status, herein Gulf War veterans and the comparison group were combined.
Participation at Wave-1 was 66.2%. Details of recruitment were published earlier [6, 7] . In 2010-2011, Wave-1 participants (N = 2779) who were not known to be deceased and whose contact information was available, were invited to participate at Wave-2. Participation at Wave-2 was 50%. Female participants comprised about 1 percent hence only data for male participants are presented. A detailed description of the Wave-2 recruitment process is published elsewhere [8] .
Data collection
At Wave-2, health service use, dispensed pharmaceuticals and disability data for the period 01 January 2001 to 15 August 2012 were obtained through linkages of consenting participants to routinely collected data held by Medicare Australia and the Australian Department of Veterans' Affairs (DVA) (including the Repatriation Pharmaceutical Benefits Scheme, RPBS). Collective data obtained from linkages with these databases included general practitioner (GP) consultations, medical specialist doctor consultations and dispensed medications. A questionnaire was also administered to collect additional data that were unavailable through data linkages, including hospital-related visits and visits to allied health professionals (particularly visits to a physiotherapist, hydrotherapist, chiropractor, audiologist, audiometrist, social/welfare worker and alcohol/drug worker visits).
Participants' demographic characteristics, military service, general health and wellbeing (assessed using the mental health component scale (MCS) and physical health component scale (PCS) of the 12-item Short-Form Health Survey; SF-12 [9] ), symptom reporting and doctor diagnosed medical conditions were collected at Wave-1 though a postal questionnaire. Psychological outcomes were assessed at Wave-1 using the Composite International Diagnostic Interview (CIDI) version 2.1 according to DSM-IV criteria [10] . Detailed information on the administration of the CIDI has been presented previously [6] .
Data linkage
Medicare Australia [11] is a Government funded programme for all Australian residents and it covers a wide range of healthcare services. The cohort was linked to two of Medicare's databases; the Medicare Benefits Schedule (MBS) [12] and Pharmaceutical Benefits Scheme (PBS) [13] . The MBS lists all healthcare services subsidized by the government under the Medicare Scheme. The PBS lists medicines dispensed in Australia at a Government-subsidized price. Data from the RPBS, which contains a list of pharmaceuticals identical to those on the PBS and additional pharmaceuticals that are only dispensed to eligible military personnel, were obtained through data linkage with DVA.
Additionally, the DVA linkage provided data on disability compensation claims, which are claims for compensation that war veterans or military personnel submit to DVA for injuries or diseases or conditions occurring as a result of their military service. It is possible for personnel to submit multiple claims for different conditions and deployments. The data provided included the date of lodgement, type of disability and the claim decision (accepted/declined). Disabilities were listed under 13 broad disease categories, which were based on Statements of Principles (SOPs) [14] . SOPs are legislative disease-specific tools that state the factors that must exist to establish a causal connection between military service and a particular disease/injury/death.
Definition of MSI
The Wave-1 questionnaire contained a 63-item symptom checklist in which participants had to indicate whether they had experienced the listed symptoms in the preceding month. Reporting of these symptoms was used to identify participants with MSI according to a modified Centres for Disease Control and Prevention definition [15] , incorporating the definition presented by Kelsall et al. [5] and the exclusion criteria suggested by Steele (2000) [16] . MSI cases need to satisfy both of the following criteria:
(a) presence of one or more symptoms of at least moderate severity in the month preceding Wave-1 from at least three of four categories namely 'fatigue', 'psycho-physiological distress' (symptoms: vomiting, nausea, stomach cramps, diarrhoea, wheezing, indigestion, shortness of breath, dry mouth, feeling feverish, swelling of lymph glands, lump in throat, persistent cough, pain on passing urine, constipation, difficulty speaking, dizziness/fainting, loss of balance/coordination, sore throat, flatulence/burping, loss of bladder control, burning sex organs, skin ulcers and loss of appetite), 'cognitive distress' (symptoms: difficulty speaking, loss of appetite, loss of concentration, feeling distant from others, unrefreshed after sleep, forgetfulness, loss of interest in sex, sleeping difficulties, avoiding things/situations, feeling jumpy, problems with sexual functioning, distressing dreams, irritability, difficulty finding the right word, feeling disoriented, increased sensitivity to noise/light/smells and shaking) and 'arthro-neuromuscular distress' (symptoms: stiffness or pain in several joint, general muscle aches, loss of sensation in hands/feet, low back pain, tingling/burning in hands), where the latter three categories were identified through exploratory factor analysis [17] ; and (b) no medical/psychological conditions in the 12 months preceding Wave-1 participation that may have explained their symptom reporting or interfered with their symptom interpretation. The medical conditions considered were self-reported doctor diagnosis and/ or treated medical conditions of cancer, diabetes, heart disease, chronic infections, thyroid problem, liver disease, renal disease, lupus, multiple sclerosis, psoriasis, stroke or injury resulting in hospitalization for at least five days. Psychological conditions considered were major depression, post-traumatic stress disorder and alcohol use disorder which were doctor diagnosed/treated or CIDIdefined in the 12 months preceding the study participation.
Group definitions
Participants were divided into three mutually exclusive groups on the basis of the MSI definition:
(a) MSI group/cases-participants fulfilling the MSI definition; (b) chronic disease group-participants who reported ≥1 of the conditions listed under the exclusion criteria for the MSI definition (i.e. the second criterion of the MSI definition). These participants may or may not have symptoms identical to MSI; and (c) non-MSI group-participants with neither MSI nor chronic diseases.
Statistical analysis
Data were analysed using Stata version 13.1 (StataCorp, Texas, US). Continuous data were reported as means and the group means were compared using unadjusted linear regression. Skewed continuous data were summarized using medians with the lower (Q1) and upper (Q3) quartiles, and between group comparisons were done using unadjusted median/robust regression [18] . Categorical data were reported as percentages and comparisons across the three groups were done using Chi-square method of association.
Level of health service use per group was reported as either recent (occurring in the 12 months preceding Wave-2 participation) or long term (occurring anytime in the 10 years preceding Wave-2 participation). The latter was particularly used for less common outcomes like specialist doctor consultations. For all outcomes, 12 months or 10 years was in reference to the date of interview for CIDI outcomes or questionnaire completion date for all other outcomes. Poisson regression with robust variance estimator [19] was used to obtain risk ratios (RRs), with 95% confidence intervals (CIs), for the comparison of health service use and disability claims in the MSI group with the other two used as reference groups. Models for health service use outcomes were adjusted for branch of service in 1991 (Navy, Army and Air Force) and Wave-1 characteristics; age (<35, 35-39, 40-44, ≥45 years), last known rank (officer or non-officer), highest education attained (secondary, certificate/ diploma and undergraduate/postgraduate), smoking status and alcohol use (defined using a cut-off of 10 on the Alcohol Use Disorders Identification Test (AUDIT) [20, 21] . The presence of multiple disability claims per participant was accommodated in regression models by using a clustered sandwich variance estimator [22] , with each individual representing a cluster. 
Ethics approvals
Results
Of the 1356 males who participated at both Wave-1 and Wave-2, presence of MSI could be ascertained in 1288 participants and only data for these participants are presented in this paper. Based on data from Wave-1, 160 (12.4%) had MSI, 217 (16.9%) participants had at least one chronic disease or disorder and 911 (70.7%) did not have MSI or chronic diseases.
The average age of participants at Wave-1 was 39.8 years (standard deviation 6.9) and the age distribution was similar across the three groups ( Table 1 ). The MSI group had fewer Officers and Army personnel than the other two groups while hazardous alcohol use was highest among those with chronic diseases. Wave-1 general health and wellbeing (based on SF-12 scores) was significantly different across the three groups (Table 1 ). For each of MCS and PCS, lower scores indicated poorer health status. Separate comparisons of those with MSI against each of the two comparison groups showed that the MCS scores for those with MSI were significantly lower than for the non-MSI group (P < 0.001) but were comparable to the chronic disease group (P = 0.19) while PCS scores were significantly lower than those of the comparison groups.
Health service utilization
The majority (N = 1106; 86%) of participants gave consent to Medicare and/or DVA linkage. Of these, 64.4% had visited a GP in the 12 months preceding Wave-2 participation. The median number of visits was 4 (Q1 = 2, Q3 = 7) for MSI group, 3 (Q1 = 2; Q3 = 5) for non-MSI group and 4 (Q1 = 2, Q3 = 8) for the chronic disease group (P < 0.001). In the 12 months preceding Wave-2 participation, significantly more participants with MSI had at least one GP consultation compared with the non-MSI group, but no significant difference was observed with the chronic disease group (Table 2) . A similar pattern was observed with specialist consultations in the 12 months preceding Wave-2 participation (Table 2) . Further analyses comparing trends total number of GP consultations over the 10 years did not show significant differences between the MSI group and the two comparison groups (P = 0.150 for chronic disease group and P = 0.137 for non-MSI/non-chronic disease group). Table 2 also shows that about a fifth of participants with MSI and a quarter in the chronic disease group had consulted more than one specialist doctor in the 12 months preceding Wave-2, compared with 10% in the non-MSI group. Similar patterns were observed over the 10 years prior to Wave-2.
In the chronic disease group, 40.9% of participants had symptom reporting that satisfied the first criterion of the MSI definition (i.e. presence of symptoms). Further comparison in this subgroup did not reveal significant differences in GP consultations (78.1% vs. 70.2%; RR = 1.10; 95% CI = 0.91, 1.32; P = 0.341), specialist doctor consultations (27.3% vs. 16.5%; RR = 1.45; 95% CI = 0.84, 2.50; P = 0.184) or allied health professional consultations (60.2% vs. 44.1%; RR = 1.18; 95% CI = 0.87, 1.60; P = 0.275) in the past 12 months between those with symptoms and those without.
Almost half (46.3%) of MSI cases had received at least one pharmaceutical over the 12 months preceding Wave-2. This proportion was significantly greater than in the non-MSI group but similar to that observed in the chronic disease group ( Table 2 ). The median number of dispensed prescriptions for MSI cases was 12 (Q1 = 6; Q3 = 42), 8 (Q1 = 2; Q3 = 16) for non-MSI group and 24 (Q1 = 6; Q3 = 57) for chronic disease group.
In addition to medical consultations listed in Table 2 , significantly more participants in the MSI group than the non-MSI group had at least one consultation with an allied health professional but there were no significant differences with the chronic disease group (Table 3) . Table 3 shows that hospital-related visits, including hospitalizations, were significantly higher in the MSI group than the non-MSI group but comparable with the chronic disease group.
Disability claims
Disability claims data were available for those consenting to DVA linkage (MSI group N = 131, 82%; non-MSI group N = 758, 83%; chronic disease group N = 185, 85%). Half of participants with MSI submitted a disability claim (50.4%) which was one-and-a-half times more than the non-MSI group (29.0%; RR = 1.63; 95% CI = 1.33, 2.00) but not significantly different to that in the chronic disease group (40.5%; RR = 1.17; 95% CI = 0.92, 1.49). Most of those who submitted claims had at least one successful claim (87.9% in MSI group, 93.6% in non-MSI group and 92.0% in chronic disease group; P = 0.288). Consequently, significantly more MSI cases (44.3%) had submitted at least one successful disability claim in the period 2001-2012 compared with 27.2% in the non-MSI group (RR = 1.54; 95% CI = 1.23, 1.93) and 37.3% in the chronic disease group (RR = 1.13; 95% CI = 0.86, 1.47). The median number of successful claims in the MSI group was 4 (Q1 = 1; Q3 = 7) compared with 3 (Q1 = 2; Q3 = 5, P = 0.043) in non-MSI group and 4 (Q1 = 2; Q3 = 6, P > 0.999) in chronic disease group.
About a fifth (21.3%) of the 2095 disability claims submitted were made by the MSI group, while 54.6% were made by the non-MSI group and 24.1% were from the chronic disease group. Musculoskeletal/connective tissue disorders and nervous system/sensory organ-related disabilities were the most common disabilities claimed for (Table 4 ). The majority (82.2%) of nervous system/sense organs-related disability claims were for hearing loss and tinnitus. Allied health professionals were physiotherapist, hydrotherapist, chiropractor, audiologist, audiometrist, social/welfare worker, alcohol/drug worker. Data on type of disability claim were missing from data collected through linkage but cannot be inferred as missing in the whole database.
The proportion of accepted claims differed by type of disability claimed (P < 0.001). Of the seven most commonly reported disabilities, the highest acceptance rates were for skin/subcutaneous tissue, neoplasms and nervous system/sensory organs. Lower acceptance rates were found for mental disorders and digestive system disorders. With the exception of mental disorders, the proportion of accepted claims in the MSI group was similar to the other two groups. Figure 1 shows that the proportion of disabilities in accepted claims (equal to number of accepted claims for a disability divided by number of total accepted claim in the group) was similar across the three groups, except for musculoskeletal/connective tissue claims which were significantly more common in the MSI group than the chronic disease group (RR = 1.37; 95% CI = 1.04, 1.81) and mental disorder claims which were significantly less common in the MSI group than the chronic disease group (RR = 0.33; 95% CI = 0.17, 0.66).
Discussion
This study assessed and compared health service utilization among military personnel with MSI, compared with a non-MSI group and a chronic disease group, using linkages to national healthcare and veteran disability databases and self-reported data. Overall, health service use based on GP, specialist doctor and allied health consultations, and dispensed pharmaceuticals were increased in those defined as having MSI compared with those with neither MSI nor chronic disease. Health service use in those with MSI was similar to that of the chronic disease group.
Much of the research on health service use in veterans has not addressed health service use specifically for MSI cases but an earlier US study [4] among Gulf War veterans only found that MSI cases were more likely to have visited a clinic at least once in the previous 12 months and had more prescription medication, compared with those without MSI. This study's findings of elevated levels of health service use among those with MSI, which include both physical and mental health specialist use, extends previous findings from this cohort which indicated increased physical and psychological morbidity among those with MSI [23] . In addition, the increased health service use, together with the lower SF-12 scores, in this group, highlights that the general health and wellbeing of those with MSI was poorer than that of participants with neither MSI nor chronic diseases, similar to what was observed in the US study by Blanchard et al. [4] . However, exploration of further development of chronic disease(s) in any of the three study groups was not possible through the data available in this study; for instance, information on treatment received by participants and the chronology of disease/treatment/ compensation was unavailable to the study.
The similarities in health service use by those with MSI and those with chronic diseases suggests that the health services for personnel with MSI could be designed or developed in line with a health management framework for chronic conditions such as the World Health Organisation's Innovative Care for Chronic Conditions (2002) [24] . Such a framework can allow shared and improved understanding of risk factors, disease determinants and coordinated multidisciplinary provision of health services. Lange et al. [25] have also advocated for the need for a multidisciplinary team approach for the management of MSI, emphasizing that such an approach would benefit not only the health system but also the military personnel themselves. The combined need for multidisciplinary teams highlights the importance of ensuring that collaborations between clinicians are supported and developed as some clinicians highlight this as a potential inhibitor in offering patients the best care [26] . Furthermore, the similarity between the MSI and chronic disease groups in health service use could indicate the complexities inherent in the diagnosis of MSI and treatment or medical care for patients with MSI. Therefore, establishing patient-centred care could aid deeper understanding of the condition and improved patient outcomes [27] .
There is scarce published information on the levels of disability compensation sought after or received by military personnel with MSI. Our study showed that the proportion of those with MSI who had submitted a disability claim was significantly higher than that of participants with neither MSI nor chronic diseases but comparable with the chronic disease group; which was consistent with findings on health service use in these groups. However, when we assessed each claim, there were no important differences across the three groups with regards to proportion of submitted claims that were successful and the types of disabilities listed in the accepted claims. This suggests that no broad category of diseases or conditions were prominent in the MSI group. These findings also support previous findings of epidemiological studies [28, 29] and factor analyses [30, 31] conducted among Gulf War veterans which showed that the unexplained symptomatology and/or MSI reveals no specific disease/disorder. Although musculoskeletal/connective tissue-related disability claims were the most common in all three study groups, the proportion was significantly higher for MSI cases. An explanation could be that the disease group constitutes many diseases/conditions that may be used to classify patients with medically unexplained symptomatology, conditions such as fibromyalgia and arthritis.
A strength of this study was the combination of objective linkage health data (from Medicare Australia and the DVA) and self-reported data on health service use and disability claims. The use of the linkage data dealt with the possible recall bias problem faced when using selfreported data. Medical diseases/conditions were self-reported therefore reporting bias is still plausible, but however with a minimal effect as caseness was only defined after data collection and participants were not aware of the group they fell under. Also, Smith et al. [32] showed that there was general agreement between self-reported medical conditions and electronic medical records.
An additional strength of this study was that we used two comparison groups which allowed us to compare the MSI group with a healthier group (non-MSI group) and a less healthy group (chronic disease group). This paper also addresses health service use measures (i.e. specialist medical doctor consultations, hospital services utilization other than hospitalization as well as consultations with allied health professionals) and disability compensation which have not been previously explored in military personnel with MSI.
A further strength of the paper was the use of a stringent definition of MSI which aided in reducing classification bias in MSI definition by separating out participants who had chronic diseases/ illnesses that could distort their symptomatology. The list of exclusionary medical conditions used for the MSI definition were based on those medical conditions previously utilized by Steele (2000) [16] and were also available in our study. Given so, it is possible that some participants with conditions such as dementia and neuromuscular disease could have been missed. However, given the comprehensiveness of the list used in defining MSI, the majority of participants with conditions that were likely to influence their symptom reporting were most likely to have been captured.
A limitation of the study was the relatively low participation at Wave-2. However, previously published tests of participation bias based on comparing Wave-1 characteristics (SF-12 scores and symptomatology) of Wave-2 participants and non-participants did not reveal significant differences in the health of the two groups [8, 33] . Although there was further minor attrition because some participants did not provide consent to Medicare and DVA linkages, the majority of Wave-2 participants had consented to the linkage. Additionally, it is possible that some specialist medical doctor consultations were not identified in the data if the costs were borne by participants and not claimed through Medicare. However, the effect of this linkage bias is likely to be limited and even more for general practice consultations because these consultations are largely subsidized by Medicare.
Conclusion
In summary, we found significantly increased health service use and disability compensation claims in military personnel with MSI compared to those with neither MSI nor chronic diseases. However, we also found that health service use and disability compensation claims overall were similar in those with MSI and those with chronic diseases based on objective and self-reported data. These results indicate that health service use for personnel with MSI is high and further research would be required to assess this group's access to and adequacy of available health services. The MSI group also accessed a combination of physical and mental health services indicating the need for coordinated and multidisciplinary healthcare provision, with a combination of health services that can cater for both physical and mental health. Furthermore, tools such as SEQUenCE, which is a reliable tool for evaluating quality of care/service at an individual level, could be used to ensure suitability of services provided [34] . In May 2014, a SOP for MSI was introduced for Australian military personnel [14] . Hence data relating to this SOP were unavailable when the data linkage for this study was conducted. Future research would need to consider an assessment of disability compensation among MSI cases post introduction of this SOP.
